Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03915431
PHASE1/PHASE2

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Sponsor: NC Medial Research Inc

View on ClinicalTrials.gov

Summary

This is an initial Phase1/2 dose-finding, randomized, multi-center study to evaluate the safety and tolerability of NCS-01 in patients with acute ischemic stroke. All patients will be randomized within 48 hours of stroke onset. This study will be conducted in 2 stages.

Official title: A Phase 1/2 Randomized Study to Evaluate the Safety and Tolerability of Intracarotid Artery Administration of NCS-01 in Patients With Acute Ischemic Stroke

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

16

Start Date

2020-02-27

Completion Date

2028-10

Last Updated

2025-09-11

Healthy Volunteers

No

Conditions

Interventions

BIOLOGICAL

NCS-01

single infusion

Locations (1)

University of Miami

Miami, Florida, United States